Literature DB >> 17331034

Oral attenuated Salmonella enterica serovar Typhimurium vaccine expressing codon-optimized HIV type 1 Gag enhanced intestinal immunity in mice.

Yasuko Tsunetsugu-Yokota1, Masayuki Ishige, Masahiro Murakami.   

Abstract

Oral immunization is a safe and easily applicable route to induce mucosal immunity to HIV infection. We examined the ability of oral attenuated Salmonella typhimurium (ST) vaccine expressing Gag for the efficiency of generating Gag-specific mucosal IgA and CD8+ T cell responses in intestinal lymphoid tissues. By optimizing the codon of HIV-1 gag to the preferred codon bias of Salmonella, the expression of Gag in Salmonella was dramatically improved. The oral ST-Gag vaccine by itself was not so powerful and induces little Gag-specific CD8+ T cell responses in the intestine. Nevertheless, we found that it potentiates otherwise weak intestinal CD8+ T cell responses in nasally primed mice with Gag p24 and cholera toxin adjuvant. Thus, the oral delivery of Salmonella expressing Gag would be utilized in combination with other parenteral vaccine to direct and strengthen intestinal HIV-specific CTL responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331034     DOI: 10.1089/aid.2006.0098

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  The cellular factors Vps18 and Mon2 are required for efficient production of infectious HIV-1 particles.

Authors:  Yuriko Tomita; Takeshi Noda; Ken Fujii; Tokiko Watanabe; Yuko Morikawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

2.  Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors.

Authors:  Edwin R Manuel; Céline A Blache; Rebecca Paquette; Teodora I Kaltcheva; Hidenobu Ishizaki; Joshua D I Ellenhorn; Michael Hensel; Leonid Metelitsa; Don J Diamond
Journal:  Cancer Res       Date:  2011-04-28       Impact factor: 12.701

3.  Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein.

Authors:  Lindsay J Hall; Simon Clare; Derek Pickard; Simon O Clark; Dominic L F Kelly; Moataz Abd El Ghany; Christine Hale; Jes Dietrich; Peter Andersen; Philip D Marsh; Gordon Dougan
Journal:  Vaccine       Date:  2009-09-13       Impact factor: 3.641

4.  Efavirenz enhances HIV-1 gag processing at the plasma membrane through Gag-Pol dimerization.

Authors:  Sho Sudo; Hiyori Haraguchi; Yoko Hirai; Hiroyuki Gatanaga; Jun-ichi Sakuragi; Fumitaka Momose; Yuko Morikawa
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

5.  Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice.

Authors:  Nyasha Chin'ombe; William R Bourn; Anna-Lise Williamson; Enid G Shephard
Journal:  Virol J       Date:  2009-06-25       Impact factor: 4.099

6.  A large extension to HIV-1 Gag, like Pol, has negative impacts on virion assembly.

Authors:  Hiyori Haraguchi; Takeshi Noda; Yoshihiro Kawaoka; Yuko Morikawa
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

Review 7.  Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.

Authors:  Nyasha Chin'ombe
Journal:  Viruses       Date:  2013-08-28       Impact factor: 5.048

8.  Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines.

Authors:  Nyasha Chin'ombe; Vurayai Ruhanya
Journal:  Open Virol J       Date:  2013-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.